McMaster University and MIT discover new antibiotic for IBD
Researchers from Canada’s McMaster University and the Massachusetts Institute of Technology in the US have discovered a new antibiotic to…
All articles by Gullapalli Prasanna
Gullapalli Prasanna
-
-
Health Canada approves Santhera’s Agamree to treat DMD
Health Canada has approved Santhera Pharmaceuticals’ Agamree (vamorolone) to treat Duchenne muscular dystrophy (DMD) in individuals aged four years and…
-
Klotho to acquire Turn Biotechnologies’ assets
Biogenetics company Klotho Neurosciences has announced plans to acquire assets from Turn Biotechnologies, marking a move in the development of…
-
Star Therapeutics gains $125m Series D funds to develop pipeline
Star Therapeutics has completed a Series D funding round, raising $125m aimed at supporting its pipeline progression. The oversubscribed round…
-
NMPA approves Eisai and Biogen for Leqembi IV maintenance dosing
China's National Medical Products Administration (NMPA) has granted approval for four-weekly intravenous (IV) maintenance dosing of Eisai and Biogen’s Leqembi…
-
Genmab to acquire Merus shares for $8bn
Genmab has signed an agreement to buy all shares of clinical-stage biotechnology company Merus at $97 per share, in an…
-
Regeneron’s Evkeeza gains FDA approval for young HoFH patients
The US Food and Drug Administration (FDA) has expanded the approval of Regeneron Pharmaceuticals' fully human monoclonal antibody, Evkeeza (evinacumab-dgnb),…
-
Amgen to invest $650m in US manufacturing network expansion
Global biotechnology company Amgen has revealed a significant investment plan, earmarking $650m to enhance its manufacturing operations in the US. The…
-
EC approves Servier’s Voranigo to treat IDH-mutant glioma
The European Commission (EC) has sanctioned the use of Servier’s Voranigo (vorasidenib) to treat certain brain tumours, specifically non-enhancing grade…
-
VectorY enters agreement with Shape Therapeutics for AAV capsid
VectorY Therapeutics has signed an agreement securing an exclusive option to assess Shape Therapeutics’ SHP-DB1 adeno-associated virus (AAV) capsid for…